Efficacy News and Research

RSS
Shire receives FDA approval of Daytrana for ADHD in adolescents

Shire receives FDA approval of Daytrana for ADHD in adolescents

Experts show the continuing global impact of Framingham Heart Study

Experts show the continuing global impact of Framingham Heart Study

Crux Biomedical commences enrollment in Retrieve 2 pivotal U.S. IDE trial of new Vena Cava Filter

Crux Biomedical commences enrollment in Retrieve 2 pivotal U.S. IDE trial of new Vena Cava Filter

PuraMed BioScience completes clinical study of LipiGesic M for treating acute migraine

PuraMed BioScience completes clinical study of LipiGesic M for treating acute migraine

Three Rivers Pharmaceuticals receives FDA expanded labeling for INFERGEN

Three Rivers Pharmaceuticals receives FDA expanded labeling for INFERGEN

Preclinical efficacy data of Sangamo's ZFN based human stem cell therapy for HIV published

Preclinical efficacy data of Sangamo's ZFN based human stem cell therapy for HIV published

Amorfix partners with reMYND to offer A4 amyloid testing services

Amorfix partners with reMYND to offer A4 amyloid testing services

EC approves change in posology of Circadin from 3 weeks to 3 months of treatment

EC approves change in posology of Circadin from 3 weeks to 3 months of treatment

Quintiles announces strategic alliance agreement with UMMC as part of Prime Site program

Quintiles announces strategic alliance agreement with UMMC as part of Prime Site program

Strativa receives FDA approval for Zuplenz oral soluble film

Strativa receives FDA approval for Zuplenz oral soluble film

Watson acquires U.S. rights to CRINONE, PROCHIEVE product line from Columbia Laboratories

Watson acquires U.S. rights to CRINONE, PROCHIEVE product line from Columbia Laboratories

Shire presents positive data from TKT-025 EXT Phase I/II study for VPRIV in type 1 Gaucher disease patients

Shire presents positive data from TKT-025 EXT Phase I/II study for VPRIV in type 1 Gaucher disease patients

Columbia Laboratories shareholders approve Watson's aquisition terms

Columbia Laboratories shareholders approve Watson's aquisition terms

Clemizole can yield high-level synergy with protease inhibitor class: Research

Clemizole can yield high-level synergy with protease inhibitor class: Research

Chelsea reports positive outcome from DMC review of droxidopa Phase II trial in fibromyalgia

Chelsea reports positive outcome from DMC review of droxidopa Phase II trial in fibromyalgia

USPTO awards Furiex method patent for dapoxetine in treatment of premature ejaculation

USPTO awards Furiex method patent for dapoxetine in treatment of premature ejaculation

Studies on VIAject and Vialog presented at 70th American Diabetes Association sessions

Studies on VIAject and Vialog presented at 70th American Diabetes Association sessions

Study results of triple combination therapy in patients with diabetes and hypertension presented at ADA 2010

Study results of triple combination therapy in patients with diabetes and hypertension presented at ADA 2010

USPTO grants Semafore method patent for PI3K inhibitors

USPTO grants Semafore method patent for PI3K inhibitors

Researchers to study interventional endovascular therapy on symptoms and progression of MS

Researchers to study interventional endovascular therapy on symptoms and progression of MS

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.